tyrphostin a23 has been researched along with Cancer of Kidney in 1 studies
tyrphostin A23: inhibits EGF-stimulated thymidine incorporation as well as EGF-stimulated receptor autophosphorylation & tyrosine phosphorylation & cell proliferation; structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Laping, NJ | 1 |
| Olson, BA | 1 |
| DeWolf, RE | 1 |
| Albrightson, CR | 1 |
| Fredrickson, T | 1 |
| King, C | 1 |
| Chirivella, M | 1 |
| Ziyadeh, FN | 1 |
| Nambi, P | 1 |
1 other study available for tyrphostin a23 and Cancer of Kidney
| Article | Year |
|---|---|
Activation of glomerular mesangial cells by hepatocyte growth factor through tyrosine kinase and protein kinase C.
Topics: Androstadienes; Animals; Catechols; Cells, Cultured; Cryopreservation; Enzyme Inhibitors; Epidermal | 1998 |